Resolution of psoriasis by a leukocyte-targeting bacterial protein in a humanized mouse model

Journal of Investigative Dermatology

Volumn 131, Issue 10, 2011, Pages 2033-2039

  Stenderup, Karin ^a   Rosada, Cecilia ^a   Dam, Thomas N ^b   Salerno, Erica ^c   Belinka, Benjamin A ^d   Kachlany, Scott C ^c,d  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ROSKILDE HOSPITAL   (Denmark)

^c RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

^d Actinobac Biomed   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFALIZUMAB; LEUKOTOXIN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD25+ T LYMPHOCYTE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; XENOGRAFT;

EID: 80052860570     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.161     Document Type: Article

References (62)

1. Abraham C, Griffith J, Miller J (1999) The dependence for leukocyte function-associated antigen-1/ICAM-1 interactions in T cell activation cannot be overcome by expression of high density TCR ligand. J Immunol 162:4399-405 (Pubitemid 29314835)
2. Baeten D, Boots AM, Steenbakkers PG et al. (2000) Human cartilage gp-39+, CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum 43: 1233-43 (Pubitemid 30416308)
3. Baker BS, Brown DW, Fischetti VA et al. (2001) Skin T cell proliferative response to M protein and other cell wall and membrane proteins of group A streptococci in chronic plaque psoriasis. Clin Exp Immunol 124:516-21 (Pubitemid 32701717)
4. Baker BS, Laman JD, Powles A et al. (2006) Peptidoglycan and peptidoglycan-specific Th1 cells in psoriatic skin lesions. J Pathol 209:174-81 (Pubitemid 43805412)
5. Bernstein CN, Sargent M, Rector E (2002) Alteration in expression of beta 2 integrins on lamina propria lymphocytes in ulcerative colitis and Crohn's disease. Clin Immunol 104:67-72 (Pubitemid 34856510)
6. Boehncke WH, Ochsendorf FR, Noll S et al. (2005) Efficacy of the fully human monoclonal antibody MOR102 (#5) against intercellular adhesion molecule 1 in the psoriasis-severe combined immunodeficient mouse model. Br J Dermatol 153:758-66 (Pubitemid 41415902)
7. Camacho SA, Heath WR, Carbone FR et al. (2001) A key role for ICAM-1 in generating effector cells mediating inflammatory responses. Nat Immunol 2:523-9 (Pubitemid 33705854)
8. Chirathaworn C, Kohlmeier JE, Tibbetts SA et al. (2002) Stimulation through intercellular adhesion molecule-1 provides a second signal for T cell activation. J Immunol 168:5530-7 (Pubitemid 34556132)
9. Chiu YG, Shao T, Feng C et al. (2010) CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis. Arthritis Res Ther 12:R14
10. Connolly MK, Kitchens EA, Chan B et al. (1994) Treatment of murine lupus with monoclonal antibodies to lymphocyte function-associated antigen-1: dose-dependent inhibition of autoantibody production and blockade of the immune response to therapy. Clin Immunol Immunopathol 72:198-203 (Pubitemid 24259435)
11. Conrad C, Boyman O, Tonel G et al. (2007) Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis. Nat Med 13:836-42 (Pubitemid 47038192)
12. Dam TN, Kang S, Nickoloff BJ et al. (1999) 1alpha,25-dihydroxycholecalci- ferol and cyclosporine suppress induction and promote resolution of psoriasis in human skin grafts transplanted on to SCID mice. J Invest Dermatol 113:1082-9 (Pubitemid 30013357)
13. de Boer OJ, Wakelkamp IM, Pals ST et al. (1994) Increased expression of adhesion receptors in both lesional and non-lesional psoriatic skin. Arch Dermatol Res 286:304-11 (Pubitemid 24223610)
14. Diaz R, Ghofaily LA, Patel J et al. (2006) Characterization of leukotoxin from a clinical strain of Actinobacillus actinomycetemcomitans. Microb Pathog 40:48-55 (Pubitemid 43221898)
15. Elovaara I, Lalla M, Spare E et al. (1998) Methylprednisolone reduces adhesion molecules in blood and cerebrospinal fluid in patients with MS. Neurology 51:1703-8 (Pubitemid 28565256)
16. Elovaara I, Ukkonen M, Leppakynnas M et al. (2000) Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylpredni-solone therapy. Arch Neurol 57:546-51 (Pubitemid 30212129)
17. Fingerle G, Pforte A, Passlick B et al. (1993) The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 82:3170-6 (Pubitemid 23334947)
18. Gilhar A, David M, Ullmann Y et al. (1997) T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice. J Invest Dermatol 109:283-8 (Pubitemid 27394638)
19. Harper EG, Simpson EL, Takiguchi RH et al. (2008) Efalizumab therapy for atopic dermatitis causes marked increases in circulating effector memory CD4+ T cells that express cutaneous lymphocyte antigen. J Invest Dermatol 128:1173-81 (Pubitemid 351543209)
20. Hasegawa Y, Yokono K, Taki T et al. (1994) Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1mAb. Int Immunol 6:831-8 (Pubitemid 24183317)
21. Hogg N, Harvey J, Cabanas C et al. (1993) Control of leukocyte integrin activation. Am Rev Respir Dis 148:S55-9 (Pubitemid 24002520)
22. Hogg N, Smith A, McDowall A et al. (2004) How T cells use LFA-1 to attach and migrate. Immunol Lett 92:51-4 (Pubitemid 38470050)
23. Jakobsen M, Stenderup K, Rosada C et al. (2009) Amelioration of psoriasis by anti-TNF-alpha RNAi in the xenograft transplantation model. Mol Ther 17:1743-53
24. Jullien D, Prinz JC, Langley RG et al. (2004) T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): mechanisms of action. Dermatology 208:297-306 (Pubitemid 38736650)
25. Kachlany SC (2010) Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy. J Dent Res 89:561-70
26. Kachlany SC, Schwartz AB, Balashova NV et al. (2010) Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells. Leuk Res 34:777-85
27. Kandula S, Abraham C (2004) LFA-1 on CD4+ T cells is required for optimal antigen-dependent activation in vivo. J Immunol 173:4443-51 (Pubitemid 39280674)
28. Kevil CG, Hicks MJ, He X et al. (2004) Loss of LFA-1, but not Mac-1, protects MRL/MpJ-Fas(lpr) mice from autoimmune disease. Am J Pathol 165: 609-16 (Pubitemid 38971390)
29. Kinashi T (2005) Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol 5:546-59 (Pubitemid 40961332)
30. Kootstra CJ, Van Der Giezen DM, Van Krieken JH et al. (1997) Effective treatment of experimental lupus nephritis by combined administration of anti-CD11a and anti-CD54 antibodies. Clin Exp Immunol 108:324-32 (Pubitemid 27223474)
31. Korostoff J, Wang JF, Kieba I et al. (1998) Actinobacillus actinomycetemco-mitans leukotoxin induces apoptosis in HL-60 cells. Infect Immun 66:4474-83 (Pubitemid 28402727)
32. Korostoff J, Yamaguchi N, Miller M et al. (2000) Perturbation of mitochondrial structure and function plays a central role in Actinobacillus actinomy-cetemcomitans leukotoxin-induced apoptosis. Microb Pathog 29:267-78
33. Koszik F, Stary G, Selenko-Gebauer N et al. (2010) Efalizumab modulates T cell function both in vivo and in vitro. J Dermatol Sci 60:159-66
34. Kunz M (2009) Current treatment of psoriasis with biologics. Curr Drug Discov Technol 6:231-40
35. Lally ET, Kieba IR, Sato A et al. (1997) RTX toxins recognize a beta2 integrin on the surface of human target cells. J Biol Chem 272:30463-9
36. Lamell CW, Griffen AL, McClellan DL et al. (2000) Acquisition and colonization stability of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in children. J Clin Microbiol 38:1196-9 (Pubitemid 30140584)
37. Leys EJ, Griffen AL, Strong SJ et al. (1994) Detection and strain identification of Actinobacillus actinomycetemcomitans by nested PCR. J Clin Microbiol 32:1288-94 (Pubitemid 24132561)
38. Linn T, Strate C, Federlin K et al. (1994) Intercellular adhesion molecule-1 (ICAM-1) expression in the islets of the non-obese diabetic and low-dose streptozocin-treated mouse. Histochemistry 102:317-21
39. Lou J, Chofflon M, Juillard C et al. (1997) Brain microvascular endothelial cells and leukocytes derived from patients with multiple sclerosis exhibit increased adhesion capacity. Neuroreport 8:629-33 (Pubitemid 27128206)
40. McGregor JM, Barker JN, Ross EL et al. (1992) Epidermal dendritic cells in psoriasis possess a phenotype associated with antigen presentation: in situ expression of beta 2-integrins. J Am Acad Dermatol 27:383-8
41. Mysliwiec J, Kretowski A, Kinalski M et al. (1999) CD11a expression and soluble ICAM-1 levels in peripheral blood in high-risk and overt type 1 diabetes subjects. Immunol Lett 70:69-72 (Pubitemid 29443917)
42. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361: 496-509
43. Nickoloff BJ (2000) Characterization of lymphocyte-dependent angiogenesis using a SCID mouse: human skin model of psoriasis. J Investig Dermatol Symp Proc 5:67-73 (Pubitemid 32044092)
44. Poulin Y, Langley RG, Teixeira HD et al. (2009) Biologics in the treatment of psoriasis: clinical and economic overview. J Cutan Med Surg 13(Suppl 2):S49-57
45. Rosada C, Stenderup K, de Darko E et al. (2010) Valrubicin in a topical formulation treats psoriasis in a xenograft transplantation model. J Invest Dermatol 130:455-63
46. Somoza N, Vargas F, Roura-Mir C et al. (1994) Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J Immunol 153:1360-77 (Pubitemid 24228529)
47. Stenderup K, Rosada C, Worsaae A et al. (2009) Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model. Br J Dermatol 160:284-96
48. Sterry W, Bagot M, Ferrandiz C et al. (2009) Immunosuppressive therapy in dermatology and PML. J Dtsch Dermatol Ges 7:5
49. Strauss-Ayali D, Conrad SM, Mosser DM (2007) Monocyte subpopulations and their differentiation patterns during infection. J Leukoc Biol 82:244-52 (Pubitemid 47230633)
50. Takasaki Y, Abe K, Tokano Y et al. (1999) The expression of LFA-1, ICAM-1, CD80 and CD86molecules in lupus patients: implication for immuno-therapy. Intern Med 38:175-7
51. Thepen T, van Vuuren AJ, Kiekens RC et al. (2000) Resolution of cutaneous inflammation after local elimination of macrophages. Nat Biotechnol 18:48-51 (Pubitemid 30041171)
52. Todd I, Radford PM, Ziegler-Heitbrock L et al. (2007) Elevated CD16 expression by monocytes from patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 56:4182-8 (Pubitemid 350262346)
53. Vainer B, Nielsen OH, Horn T (2000) Comparative studies of the colonic in situ expression of intercellular adhesion molecules (ICAM-1,-2, and-3), beta2 integrins (LFA-1, Mac-1, and p150,95), and PECAM-1 in ulcerative colitis and Crohn's disease. Am J Surg Pathol 24: 1115-24 (Pubitemid 30612833)
54. Valdimarsson H, Thorleifsdottir RH, Sigurdardottir SL et al. (2009) Psoriasis-as an autoimmune disease caused by molecular mimicry. Trends Immunol 30:494-501
55. van den Oord JJ, de Wolf-Peeters C (1994) Epithelium-lining macrophages in psoriasis. Br J Dermatol 130:589-94 (Pubitemid 24204694)
56. Vestergaard C, Just H, Baumgartner Nielsen J et al. (2004) Expression of CCR2 on monocytes and macrophages in chronically inflamed skin in atopic dermatitis and psoriasis. Acta Derm Venereol 84:353-8 (Pubitemid 39312267)
57. Villadsen LS, Schuurman J, Beurskens F et al. (2003) Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. J Clin Invest 112:1571-80 (Pubitemid 38056283)
58. Villadsen LS, Skov L, Dam TN et al. (2007) In situ depletion of CD4+ T cells in human skin by Zanolimumab. Arch Dermatol Res 298: 449-55 (Pubitemid 46144206)
59. Watts GM, Beurskens FJ, Martin-Padura I et al. (2005) Manifestations of inflammatory arthritis are critically dependent on LFA-1. J Immunol 174:3668-75 (Pubitemid 40354077)
60. Wrone-Smith T, Nickoloff BJ (1996) Dermal injection of immunocytes induces psoriasis. J Clin Invest 98:1878-87 (Pubitemid 26359206)
61. Zeigler M, Chi Y, Tumas DB et al. (2001) Anti-CD11a ameliorates disease in the human psoriatic skin-SCID mouse transplant model: comparison of antibody to CD11a with cyclosporin A and clobetasol propionate. Lab Invest 81:1253-61 (Pubitemid 32911974)
62. Ziegler-Heitbrock L (2007) The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 81:584-92 (Pubitemid 46393535)